Register to chat with like-minded investors on our interactive forums.

Get Started

AKBA Akebia Therapeutics Inc

1.36

0.01 (0.74%)

After Hours

Last Updated: 17:48:17

Delayed by 15 minutes

Akebia highlights late-stage vadadustat kidney disease study results

To read the full story on Seeking Alpha, click here.

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Akebia Therapeutics Charts.

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Akebia Therapeutics Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Akebia Therapeutics Inc News

More Akebia Therapeutics Inc News Articles

Sincerity Applied Materi... (PK)

Brookmount Explorations (PK)

TransCode Therapeutics

Net Savings Link (PK)

Premier Biomedical (PK)

Clean Vision (QB)

Revance Therapeutics

NFT MarketPlace (PK)

Delayed Upgrade Clock